Table of Content

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of Chronic Kidney Diseases
4.2.2 Increasing Awareness about the Diagnostic Methods for the Proper Functioning of the Kidney
4.2.3 Technological Advancements in Diagnostic Machinery and Tools
4.3 Market Restraints
4.3.1 High Cost of Diagnostic Procedures
4.3.2 Stringent Regulations Norms
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Dipsticks
5.1.2 Disposables
5.1.3 Reagents
5.2 By Test Type
5.2.1 Blood Tests
5.2.2 Urine Tests
5.2.3 Imaging Tests
5.2.4 Other tests
5.3 By End-user
5.3.1 Hospitals and clinics
5.3.2 Diagnostic laboratories
5.3.3 Other end-users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 F.Hoffmann-La Roche Ltd
6.1.2 Danaher Corporation (Beckman Coulter, Inc)
6.1.3 Siemens Healthineers
6.1.4 Cook Medical
6.1.5 C. R. Bard, Inc
6.1.6 Baxter International Inc
6.1.7 Abbott Laboratories
6.1.8 Nova Biomedical
6.1.9 Boston Scientific Corporation
6.1.10 Sysmex


7 MARKET OPPORTUNITIES AND FUTURE TRENDS